Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Metastatic or Unresectable Melanoma: Proof-of-Principle Pilot Trial
DRKS00003495Phase 2Not yet recruiting
- Sponsor
- Heidelberg University Hospital
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tadalafil in melanoma, sponsored by Heidelberg University Hospital. Planned start Jan 2012; status: not yet recruiting.
02
Drugs
tadalafil
03
Conditions
melanoma
Beyond the preview
Go deeper on DRKS00003495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003495.